Overexpression of EGFR is implicated in the pathogenesis of many human cancers, including NSCLC (Bethune et al. 2010) and has been known to correlate with poor prognosis (Ohsaki et al. 2000). This evidence concerns the gene EGFR and non-small cell lung carcinoma.